Oligodendroglioma Latest Advances

The role of immunohistochemical CIC expression in oligodendrogliomas for recurrence risk stratification.

Journal: Clinical neuropathology

Published: January 19, 2026

Differential diagnosis of high-grade astrocytic gliomas based on CD44, SOX2, and CIRBP gene expression analysis

Journal: Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko

Published: January 13, 2026

Polymorphous low-grade neuroepithelial tumor of the young: a molecular pathological study

Journal: Zhonghua bing li xue za zhi = Chinese journal of pathology

Published: January 06, 2026

Analysis of outcomes of patients with oligodendroglioma with focus on volumetric reduction.

Journal: Neuro-oncology practice

Published: December 29, 2025

Presenting clinical and radiographic features of diffuse glioma molecular subtypes in accordance with the 2021 CNS5 WHO classification.

Journal: Neuro-oncology practice

Published: December 29, 2025

Immunophenotypic characterization of canine oligodendroglioma cells cultured in an oligodendrocyte precursor cell-tailored medium.

Journal: The Journal of veterinary medical science

Published: December 17, 2025

Molecular subtype-driven surgical concepts and clinical application in gliomas

Journal: Zhonghua wai ke za zhi [Chinese journal of surgery]

Published: November 26, 2025

Differences in Executive Functioning Between Patients with IDH1-Mutant Oligodendroglioma and Astrocytoma Before and After Surgery.

Journal: Cancers

Published: November 20, 2025

Clinical predictors of overall survival in elderly oligodendroglioma patients: A Surveillance, Epidemiology, and End Results (SEER) database analysis.

Journal: Clinical neurology and neurosurgery

Published: November 19, 2025

Comparing Isocitrate Dehydrogenase Inhibitors with Procarbazine, Lomustine, and Vincristine Chemotherapy for Oligodendrogliomas.

Journal: Cancers

Published: November 13, 2025

Corrigendum to "The relationships of platelet-derived growth factor, microvascular proliferation, and tumor cell proliferation in canine high-grade oligodendrogliomas: Immunohistochemistry of 45 tumors and an AFOB-01 xenograft mouse model".

Journal: Veterinary pathology

Published: November 04, 2025

Distinct molecular profiles characterize the spontaneous growth rate of IDHmt low-grade astrocytomas and oligodendrogliomas.

Journal: Neuro-oncology

Published: October 21, 2025